Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Acorda Therapeutics, Inc. (Nasdaq: ACOR) will present new research data on AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg at the 5th Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), being held in Orlando, FL, May 29 – June 1. AMPYRA is an FDA-approved therapy indicated to improve walking in people with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.
Help employers find you! Check out all the jobs and post your resume.
